Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 378f (miR-378f) is a small, noncoding RNA molecule that is part of the miR-378 family. Like other microRNAs, miR-378f regulates gene expression by base-pairing with target mRNA transcripts, causing their degradation or inhibiting translation. The miR-378 family (including miR-378, miR-378a, miR-378b, etc.) has been shown to play significant roles in cancer progression (regulation of tumor suppressors such as Sufu and Fus-1), cell survival, proliferation, migration, and differentiation. miR-378 family members have tissue- and context-specific functions, and contribute to both normal developmental and disease processes. The role of miR-378f specifically is presumably similar to its closely related family members, but high-confidence, functionally distinct studies on the "f" variant are currently limited in the public literature. If you need structured information on other miR-378 variants (such as "miR-378a" or "miR-378b"), these are more widely studied. For miR-378f, current knowledge is primarily inferred from general miR-378 family research.
MicroRNAs, including miR-378f, act by binding to complementary sequences in the 3′ untranslated region (3′UTR) of messenger RNAs (mRNAs) of target genes, resulting in: - Translational repression or mRNA degradation of target genes Therapeutic inhibitors (antagomirs, antimiRs) would block miR-378f function and potentially de-repress target gene expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 378f (miR-378f).